Hans Nauwynck

usuarios_autor_invitado Autor

Hans Nauwynck is born on May 2nd, 1963 in Torhout, Belgium. He graduated as Doctor in Veterinary Medicine in 1987 at Ghent University. In 1993, he got his PhD degree, Doctor in Veterinary Sciences and became nominated as assistant professor at Ghent University. Afterwards, he promoted to associate professor in 1999 and full professor in 2004. In 2004, he took the lead of the Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University and became Diplomate at the European College of Pig Health Management. At present, he lectures several courses on viral diseases in mammals. His research focuses on cellular and molecular pathogenesis of viral diseases in man and animal, with special emphasis on the entry of the virus in its host cell, the invasion of the virus in its host through barriers, via leukocytes and along neurons and the escape of the virus from immunity. Better insights lead to research-driven development of new generation treatments and vaccines. He is author of 285 papers and several patents and is a frequent speaker during international veterinary and virology congresses. At present, his staff consists of 25 PhD students, 4 post-docs and 14 technicians.

PRRS: futuras linhas de investigação

Neste artigo desta série, com o Dr. Hans Nauwynck (Universidade de Gante, Bélgica), revemos a sua opinião sobre as principais lacunas que existem na investigação da PRRSV e como vislumbra o futuro desta doença ao considerar tecnologias de diagnóstico e estratégias de vacinação.

Hans Nauwynck: compreender os vírus da célula à exploração

Entrevistámos Hans Nauwynck, que se define como um virologista veterinário. Um profissional que trabalha em laboratório com precisão cirúrgica, procurando perceber como os vírus animais interagem com as suas células-alvo. Mas o seu trabalho vai mais longe: graças ao seu profundo conhecimento do comportamento biológico dos vírus, consegue explicar claramente muitos dos "porquês" essenciais para a compreensão da patogénese das doenças virais e para o desenvolvimento de estratégias de controlo eficazes.